Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial

Published:2020-12 Issue:6 Volume:146 Page:1397-1405
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Roufosse Florence,Kahn Jean-Emmanuel,Rothenberg Marc E.,Wardlaw Andrew J.,Klion Amy D.,Kirby Suyong Yun,Gilson Martyn J.,Bentley Jane H.,Bradford Eric S.,Yancey Steven W.,Steinfeld Jonathan,Gleich Gerald J.

Funder

GlaxoSmithKline

GSK

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference18 articles.

1. Hypereosinophilic syndrome;Curtis;Clin Rev Allergy Immunol,2016

2. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy;Ogbogu;J Allergy Clin Immunol,2009

3. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management;Shomali;Am J Hematol,2019

4. Anti-inflammatory glucocorticoid drugs: reflections after 60 years;Whitehouse;Inflammopharmacology,2011

5. (A critical appraisal of) classification of hypereosinophilic disorders;Kahn;Front Med (Lausanne),2017

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eosinophils and T2 inflammation in severe asthma;Exploration of Asthma & Allergy;2024-08-13

2. Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach;World Allergy Organization Journal;2024-08

3. Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis;Immunology and Allergy Clinics of North America;2024-08

4. Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals;Current Hematologic Malignancy Reports;2024-07-22

5. Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC);Cells;2024-07-11